Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Tirzepatide activates both GIP and GLP-1 receptors (dual agonist), while semaglutide only targets GLP-1
and Lou et al
Nausea, reduced appetite, and changes in bowel habits typically resolve within 24 weeks as your GI tract adjusts to the new dual-pathway activation
GLP-1 receptors are widely distributed in the central nervous system, especially in regions related to appetite regulation, memory, and learning, including the hippocampus, hypothalamus, and brainstem
Patients can access semaglutide injections, tirzepatide, oral formulations, and combination therapies regardless of geographic location or insurance status
US$ 22.46
US$ 23.06
US$ 23.57
US$ 27.62
US$ 24.30
US$ 24.48
US$ 25.48
US$ 27.21
